Skip to main content
. 2024 Dec 13;16(12):1592. doi: 10.3390/pharmaceutics16121592
HIV-1 Human immunodeficiency virus
HAART Highly active antiretroviral therapy
NRTI Nucleoside reverse transcriptase inhibitor
HIV-SN HIV-related sensory neuropathy
ATN Antiretroviral toxic neuropathy
3TC Lamivudine
ABC Abacavir
AZT Zidovudine
d4T Stavudine
ddC Zalcitabine
ddI Didanosine
FTC Emtricitabine
TDF Tenofovir disoproxil fumarate
CNS Central nervous system
PNS Peripheral nervous system
SC Schwann cells
SGC Satellite glial cells